Your browser doesn't support javascript.
loading
[General characteristics and clinical practices of Chinese patients with non-alcoholic fatty liver disease].
Zeng, Min-de; Wang, Bing-yuan; Chen, Cheng-wei; Shi, Rui-hua; Li, You-ming; Hou, Xiao-hua; Xuan, Shi-ying; Zou, Xiao-ping; Li, Yu-yuan; Jiang, Jia-ji; Song, Zhen-ya; Fang, Jian-gao; Mao, Yi-min.
  • Zeng MD; Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Zhonghua Gan Zang Bing Za Zhi ; 19(5): 362-6, 2011 May.
Article en Zh | MEDLINE | ID: mdl-21645445
ABSTRACT

OBJECTIVE:

To assess the characteristics and daily treatment compliance of non-alcoholic fatty liver disease (NAFLD) patients in China.

METHODS:

NAFLD adult patients from 21 clinics of 12 cities in China were enrolled in this registry. Physical examination such as demographic characteristics (height, weight, waist circumference measurement), blood pressure and clinical laboratory and ultrasonographic examination of liver were undertaken. Daily practice including life style and medication were recorded and assessed in accordance with 2006 Chinese NAFLD treatment guidelines.

RESULTS:

A total of 1656 patients were enrolled (1146 male and 510 female), mean of 45.8 ± 12.6 years old, mean duration of NAFLD history was (47.2 ± 47.7) months. 44.9% of NAFLD were suffering from metabolic syndromes. Patients with central obesity have higher incidence of hypertension and lower level of high-density lipoprotein cholesterol (HDL-C) than those without central obesity, P < 0.05. Body mass index (BMI), waist circumference, triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C) in ALT abnormal group were higher than those in ALT normal group (P < 0.05), HDL-C was lower in ALT abnormal group (P < 0.05). Significant differences existed between the BMI, female waist circumference, TG, fast insulin, HOMA index, ALT, AST and HDL-C among subgroups with mild, moderate and severe steatosis. Majority of the patients did not follow recommendations of NAFLD treatment guidelines. Among targeted population only 15.3% of patients used insulin sensitizers and 23.8% took lipid lowering medicine according to the guideline.

CONCLUSION:

Data indicated that nearly half of NAFLD patients co-morbid with metabolic disorders. Therapy compliance was unsatisfactory and the gap between current practice and Chinese NAFLD treatment guidelines was not optimal.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hígado Graso Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: Zh Año: 2011 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hígado Graso Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: Zh Año: 2011 Tipo del documento: Article